AZURE_2A: AZURE, figure 2A

AZURE_2AR Documentation

AZURE, figure 2A

Description

Kaplan-Meier digitized data from AZURE, figure 2A (PMID 25035292). A reported sample size of 3,360 for a primary endpoint of DFS in breast cancer.

Usage

AZURE_2A

Format

A data frame of 3,359 observations and 3 variables:

time event time (in months)
event DFS event indicator (0: no event, 1: event)
arm treatment arms (control, zoledronic_acid)

Source

Coleman R, Cameron D, Dodwell D, et al. Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial. Lancet Oncol 2014; 15: 997–1006.

Examples

summary(AZURE_2A)

kmplot(AZURE_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.